Targeting the genetic alterations of the PI3K–AKT–mTOR pathway: Its potential use in the treatment of bladder cancers
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference226 articles.
1. Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer;Agarwal;BMC Cancer,2014
2. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha;Alessi;Curr Biol,1997
3. Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study;Asahina;Investig New Drugs,2013
4. AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K;Askham;Oncogene,2010
5. Somatic mutation of PTEN in bladder carcinoma;Aveyard;Br J Cancer,1999
Cited by 69 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. BHLHE41 inhibits bladder cancer progression via regulation of PYCR1 stability and thus inactivating PI3K/AKT signaling pathway;European Journal of Medical Research;2024-05-29
2. Elucidation of the Role of the Epigenetic Regulatory Mechanisms of PI3K/Akt/mTOR Signaling Pathway in Human Malignancies;Current Cancer Drug Targets;2024-03
3. UPP1 enhances bladder cancer progression and gemcitabine resistance through AKT;International Journal of Biological Sciences;2024
4. Precision medicine for urothelial carcinoma: An international perspective;Urologic Oncology: Seminars and Original Investigations;2024-01
5. The Potential of Congo Red Supplied Aggregates of Multitargeted Tyrosine Kinase Inhibitor (Sorafenib, BAY-43-9006) in Enhancing Therapeutic Impact on Bladder Cancer;International Journal of Molecular Sciences;2023-12-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3